Loss of BAF250a (ARID1A) Expression Is Associated with Progression of Endometriosis-Related Stage I Ovarian Clear Cell Carcinoma

被引：0
|
作者：
Kawabata, Ayako
Kiyokawa, Takako
Yanaihara, Nozomu
Okamoto, Aikou
机构：
[1] Jikei Univ, Sch Med, Dept Obstet & Gynecol, Tokyo, Japan
[2] Jikei Univ, Dept Pathol, Sch Med, Tokyo 105, Japan
来源：
MODERN PATHOLOGY | 2016年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1155
引用
收藏
页码：290A / 290A
页数：1
相关论文
共 50 条
  • [1] Loss of BAF250a (ARID1A) Expression Is Associated with Progression of Endometriosis-Related Stage I Ovarian Clear Cell Carcinoma
    Kawabata, Ayako
    Kiyokawa, Takako
    Yanaihara, Nozomu
    Okamoto, Aikou
    [J]. LABORATORY INVESTIGATION, 2016, 96 : 290A - 290A
  • [2] Loss of ARID1A/BAF250a expression in ovarian endometriosis and clear cell carcinoma
    Xiao, Wenbin
    Awadallah, Amad
    Xin, Wei
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2012, 5 (07): : 642 - 650
  • [3] Loss of ARID1A/BAF250a expression in endometriosis
    Noske, A.
    Samartzis, N.
    Rechsteiner, M.
    Samartzis, E.
    Imesch, P.
    Caduff, R.
    Moch, H.
    [J]. HISTOPATHOLOGY, 2012, 61 : 108 - 108
  • [4] BAF250a (ARID1A) Expression in Ovarian Clear Cell Adenocarcinoma with an Adenofibromatous Component
    Nishikimi, K.
    Kiyokawa, T.
    Tate, S.
    Iwamoto, M.
    Kisimoto, T.
    Fugo, K.
    Shozu, M.
    [J]. MODERN PATHOLOGY, 2013, 26 : 289A - 290A
  • [5] BAF250a (ARID1A) Expression in Ovarian Clear Cell Adenocarcinoma with an Adenofibromatous Component
    Nishikimi, K.
    Kiyokawa, T.
    Tate, S.
    Iwamoto, M.
    Kisimoto, T.
    Fugo, K.
    Shozu, M.
    [J]. LABORATORY INVESTIGATION, 2013, 93 : 289A - 290A
  • [6] Loss of BAF250a (ARID1A) Expression in Endometrial Clear Cell Carcinoma: Assessment of Frequency and Clinicopathologic Implications
    Fadare, O.
    Renshaw, I. L.
    Liang, S. X.
    [J]. LABORATORY INVESTIGATION, 2012, 92 : 269A - 269A
  • [7] Loss of BAF250a (ARID1A) Expression in Endometrial Clear Cell Carcinoma: Assessment of Frequency and Clinicopathologic Implications
    Fadare, O.
    Renshaw, I. L.
    Liang, S. X.
    [J]. MODERN PATHOLOGY, 2012, 25 : 269A - 269A
  • [8] The Clinicopathologic Significance of the Loss of BAF250a ( ARID1A) Expression in Endometrial Carcinoma
    Zhang, Zheng-mao
    Xiao, Shuang
    Sun, Guang-yu
    Liu, Yue-ping
    Zhang, Feng-hua
    Yang, Hong-fang
    Li, Jia
    Qiu, Hong-bing
    Liu, Yang
    Zhang, Chao
    Kang, Shan
    Shan, Bao-en
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (03) : 534 - 540
  • [9] The Clinicopathologic Significance of BAF250a (ARID1A) Expression in Hepatocellular Carcinoma
    Zhao, Jie
    Chen, Jiang
    Lin, Hui
    Jin, Renan
    Liu, Jinghua
    Liu, Xiaolong
    Meng, Ning
    Cai, Xiujun
    [J]. PATHOLOGY & ONCOLOGY RESEARCH, 2016, 22 (03) : 453 - 459
  • [10] The Clinicopathologic Significance of p53 and BAF250a (ARID1A) Expression in Clear Cell Carcinoma of the Endometrium
    Fadare, O.
    Gwin, K.
    Desouki, M. M.
    Crispens, M. A.
    Jones, H. W., III
    Khabele, D.
    Mohammed, K.
    Liang, S. X.
    Zheng, W.
    Hecht, J. L.
    Parkash, V.
    [J]. MODERN PATHOLOGY, 2013, 26 : 273A - 273A
12345